loading page

Supra-annular aortic valve replacement: technique and early outcomes
  • +1
  • Nathanael Shraer,
  • Ramzi Ramadan,
  • Alexandre Azmoun,
  • Julien Guihaire
Nathanael Shraer
Hospital Marie Lannelongue
Author Profile
Ramzi Ramadan
Hospital Marie Lannelongue
Author Profile
Alexandre Azmoun
Hospital Marie Lannelongue
Author Profile
Julien Guihaire
Hospital Marie Lannelongue
Author Profile

Abstract

OBJECTIVES: The supra-annular aortic valve replacement (SA-AVR) allows for implantation of larger prostheses. We describe the technique, early post-operative outcomes and hospital mortality. METHODS: Patients who underwent SA-AVR with the Carpentier-Edwards Magna Ease bioprosthesis between December 2010 and December 2017 were retrospectively reviewed. The prosthesis was sutured to the aortic annulus along the coronary sinuses, and in a supra-annular position along the non-coronary sinus. RESULTS: 115 patients were included (mean age: 71,6 years ± 9,4). Mean bioprosthesis diameter was 23,3 ± 1,7 mm. Four early deaths were observed in the ICU. Early post-operative complications included: re-operation for bleeding (n=6), tamponade (n=7), permanent atrioventricular block (n=4) and hemodialysis (n=2). In-hospital mortality was 3,48%. Postoperative echocardiography showed a marked decrease in the mean left ventricle – aorta gradient (50,4 ± 16,1 mmHg vs 11,3 ± 4,05 mmHg). CONCLUSION: SA-AVR is safe and associated with favourable immediate outcomes in patients with small aortic annulus.